Monthly Archives: June 2026

By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC In most companies I am fortunate to be a part of, there is a strong relationship between investors and operators. But every so

By Arthur Tzianabos, CEO of Lifordi Immunotherapeutics, as part of the From The Trenches feature of LifeSciVC We work in a serious business — endeavoring to make people’s lives better and, in some cases, literally saving lives. It is a

The rise of China in the global biopharma ecosystem has led to fear and hysteria in some corners of our ecosystem.  Apparently there have been too many deals with Chinese players by both venture investors and Big Pharma. US biotech